Henry Schein, Inc. (HSIC) is a Consumer Discretionary stock trading at $90.86 (as of 2026-09-03), with a market capitalization of $10.13B and a trailing P/E of 25.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Henry Schein, Inc. supplies health care products and services, including dental and medical offerings such as products, pharmaceuticals and vaccines, surgical and diagnostic items, and equipment, along with related repair services. It operates through Health Care Distribution and Technology and Value-Added Services, serving dental practitioners and laboratories, physician practices, government and institutional health care clinics, and other alternate care clinics.
Henry Schein sells dental supplies, equipment, and medical products to practices, labs, and clinics around the world, earning revenue through distribution and subscription software. The model leans heavily on recurring consumables within dental, with a small but growing cloud-software layer that deepens wallet share per customer.
Henry Schein's profit pool is the wholesale spread on high-volume dental and medical consumables, with a thin but growing software subscription layer that increases customer stickiness and wallet share per practice.
| Dental | $1.9B |
| Medical | $1.1B |
| Technology & Value-Added | $0.2B |
| Other | $0.3B |
Business quality (Weak): A volume distributor with a 5% operating margin and a P/E of 24.8x sitting 5% above the Wholesale industry average. The cloud-software layer is directionally promising but still small relative to the distribution base, and the overall business-quality grade is Weak.
Valuation: At 25× earnings, HSIC trades in line with the Wholesale average (24×).
| Price | $90.86 |
| Market Cap | $10.13B |
| P/E Ratio | 25.1 |
| EV / EBITDA | 11.1 |
| Price / Book | 2.65 |
| Price / Sales | 0.74 |
| FCF Yield | 5.7% |
| DCF Value (model) | $55.98 |
| DCF Upside vs Price | -38.4% |
| Revenue (TTM) | $13.18B |
| Net Margin | 3.0% |
| Revenue Growth (YoY) | 6.7% |
| EPS Growth (YoY) | 16.9% |
| FCF Growth (YoY) | 140.9% |
| Altman Z-Score | 2.77 (grey) |
| Piotroski F-Score | 4/9 (moderate) |
| Stock P/E | 25.1 |
| Sector P/E (Consumer Discretionary) | 20.2 |
| Industry P/E (Wholesale) | 23.9 |
| vs Sector | 24.6% |
| vs Industry | 5.3% |
| Top Institutional Holder | Kohlberg Kravis Roberts & Co. L.P. ($1.15B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 9 |
| Sector | Consumer Discretionary |
| Industry | Wholesale |
| CEO | Stanley Bergman |
| Employees | 25,000 |
| Country | US |
| IPO Date | 1995-11-03 |
Data as of 2026-09-03.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.